Healthcare professional reported patient believed the stomach was empty, experienced intolerance, abdominal pain, could not pass gas and was hungery.Testing confirmed the balloon deflated, migrated and caused a small bowel obstruction.The balloon was successfully removed.Patient is doing well.
|
Combined medwatch submitted to the fda on 17nov2023.A review of the device labeling notes the following: the current orbera365¿ intragastric balloon system directions for use (dfu) addresses the known and anticipated potential events of deflation, abdominal pain, obstruction, migration and early removal as follows: "the physiological response of the patient to the presence of the orbera365¿system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response." "each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms." "complications: possible complications of the use of the orbera365¿ system include: -gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.-patients reporting loss of satiety, increased hunger and/or weight gain should be examined endoscopically as this is indicative of an igb deflation.-a patient who's deflated (i.E.Collapsed) igb has moved into the intestines must be monitored closely for an appropriate period of time (at least 2 weeks) to confirm its uneventful passage through the intestine.- abdominal or back pain, either steady or cyclic.- deflation and subsequent replacement." - deflated device should be removed promptly.Possible adverse events · intestinal obstruction by the igb.An insufficiently filled igb or a leaking igb that has lost sufficient volume may be able to pass from the stomach into the small bowel.It may pass all the way into the colon and be passed with stool.However, if there is a narrow area in the bowel or adhesion formation, which may occur after previous surgery on the bowel, the igb may not pass and could cause a bowel obstruction.If this occurs, surgery or endoscopic removal could be required.· insufficient or no weight loss.· igb deflation (i.E.Collapse) and subsequent replacement.Dhr review was completed for lot number, af05136 (see ccn0008877 dhr ).The subject product met all specifications and requirements in effect at the time of manufacture. a review of the labeling for this device for this reported event can be seen below in the risk review section.Additional information: the investigator determined that a device history record (dhr) review is required for this complaint due to the complaint being mdr reportable.The subject product met all specifications and requirements in effect at the time of manufacture.There are no other complaints against this lot number, af05136, and allegation.Device evaluation summary: assessment of the device involved in this complaint was not possible, and it has not been possible to determine the root cause for this event.Lab analysis was not able to replicate the reported event of "deflation, abdominal pain, obstruction, migration and early removal ", as the device was not returned.The user effects of "deflation, abdominal pain, obstruction, migration and early removal "are known and labeled possible adverse event.
|